Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Nancy Ascher, MD, PhD

    Address513 Parnassus Ave, Med Sci
    San Francisco CA 94143
    Phone415-476-1236

       ORNG Applications 
       Websites
       Featured Videos
       In The News
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Dusch MN, O'Sullivan PS, Ascher NL. Patient perceptions of female surgeons: how surgeon demeanor and type of surgery affect patient preference. J Surg Res. 2014 Mar; 187(1):59-64.
        View in: PubMed
      2. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Ex vivo split-liver transplantation: the true right/left split. HPB (Oxford). 2014 Mar; 16(3):267-74.
        View in: PubMed
      3. Roll GR, Parekh JR, Parker WF, Siegler M, Pomfret EA, Ascher NL, Roberts JP. Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl. 2013 May; 19(5):472-81.
        View in: PubMed
      4. Trompeta JA, Cooper BA, Ascher NL, Kools SM, Kennedy CM, Chen JL. Asian American adolescents' willingness to donate organs and engage in family discussion about organ donation and transplantation. Prog Transplant. 2012 Mar; 22(1):33-40, 70.
        View in: PubMed
      5. Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl. 2012 Feb; 18(2):160-5.
        View in: PubMed
      6. Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg. 2011 Sep; 146(9):1052-9.
        View in: PubMed
      7. Melcher ML, Freise CE, Ascher NL, Roberts JP. Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant. Clin Transplant. 2010 Nov-Dec; 24(6):E230-5.
        View in: PubMed
      8. Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers. Clin Transplant. 2010 Sep-Oct; 24(5):E137-44.
        View in: PubMed
      9. Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, Fix OK, Eilers H, Feiner JR, Ascher NL, Freise CE, Bass NM. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg. 2011 Jan; 15(1):209-14.
        View in: PubMed
      10. Trompeta JA, Chen JL, Cooper BA, Ascher NL, Kools SM. Development of the Organ Donation and Transplantation Knowledge Survey for use in Asian American adolescents. Transplant Proc. 2010 Jun; 42(5):1427-31.
        View in: PubMed
      11. Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl. 2010 May; 16(5):649-57.
        View in: PubMed
      12. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27.
        View in: PubMed
      13. Cloyd J, Holtzman D, O'Sullivan P, Sammann A, Tendick F, Ascher N. Operating room assist: surgical mentorship and operating room experience for preclerkship medical students. J Surg Educ. 2008 Jul-Aug; 65(4):275-82.
        View in: PubMed
      14. Takata MC, Campos GM, Ciovica R, Rabl C, Rogers SJ, Cello JP, Ascher NL, Posselt AM. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008 Mar-Apr; 4(2):159-64; discussion 164-5.
        View in: PubMed
      15. Hirose R, Yao F, Stock P, Roberts J, Ascher N. Liver transplantation at UCSF--a 20-year experience. Clin Transpl. 2008; 119-25.
        View in: PubMed
      16. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant. 2008 Feb; 8(2):355-65.
        View in: PubMed
      17. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant. 2007 Nov; 7(11):2587-96.
        View in: PubMed
      18. Sammann A, Tendick F, Ward D, Zaid H, O'Sullivan P, Ascher N. A surgical skills elective to expose preclinical medical students to surgery. J Surg Res. 2007 Oct; 142(2):287-94.
        View in: PubMed
      19. Bartholomew A, Ascher N, Starzl T. Tribute: Dr. Olga Jonasson. Born in Peoria, Illinois, August 12, 1934. Died in Chicago, Illinois, August 30, 2006. Am J Transplant. 2007 Aug; 7(8):1882-3.
        View in: PubMed
      20. Derish PA, Maa J, Ascher NL, Harris HW. Enhancing the mission of academic surgery by promoting scientific writing skills. J Surg Res. 2007 Jun 15; 140(2):177-83.
        View in: PubMed
      21. Niemann CU, Feiner J, Behrends M, Eilers H, Ascher NL, Roberts JP. Central venous pressure monitoring during living right donor hepatectomy. Liver Transpl. 2007 Feb; 13(2):266-71.
        View in: PubMed
      22. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Paul SM, Dodd MJ, Painter PL. A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transplant. 2006 Aug; 6(8):1896-905.
        View in: PubMed
      23. Bernat JL, D'Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, Rosenbaum SH, Devita MA, Gaston RS, Merion RM, Barr ML, Marks WH, Nathan H, O'connor K, Rudow DL, Leichtman AB, Schwab P, Ascher NL, Metzger RA, Mc Bride V, Graham W, Wagner D, Warren J, Delmonico FL. Report of a National Conference on Donation after cardiac death. Am J Transplant. 2006 Feb; 6(2):281-91.
        View in: PubMed
      24. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005 Dec; 11(12):1505-14.
        View in: PubMed
      25. Derish P, Ascher NL. The Department of Surgery, University of California, San Francisco. Arch Surg. 2005 Dec; 140(12):1143-8.
        View in: PubMed
      26. Cruz E, Ascher NL, Roberts JP, Bass NM, Yao FY. High incidence of recurrence and hematologic events following liver transplantation for Budd-Chiari syndrome. Clin Transplant. 2005 Aug; 19(4):501-6.
        View in: PubMed
      27. Kusano T, Randall HB, Roberts JP, Ascher NL. The use of stents for duct-to-duct anastomoses of biliary reconstruction in orthotopic liver transplantation. Hepatogastroenterology. 2005 May-Jun; 52(63):695-9.
        View in: PubMed
      28. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005 Apr; 5(4 Pt 1):795-804.
        View in: PubMed
      29. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Dodd MJ, Painter PL. Objective measures of health-related quality of life over 24 months post-liver transplantation. Clin Transplant. 2005 Feb; 19(1):1-9.
        View in: PubMed
      30. Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl. 2004 May; 10(5):621-30.
        View in: PubMed
      31. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55.
        View in: PubMed
      32. Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split-liver transplantation in the United States: outcomes of a national survey. Ann Surg. 2004 Feb; 239(2):172-81.
        View in: PubMed
      33. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology. 2004 Jan; 39(1):230-8.
        View in: PubMed
      34. Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl. 2003 Oct; 9(10):1102-7.
        View in: PubMed
      35. Chang GJ, Mahanty HD, Ascher NL, Roberts JP. Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant. 2003 Oct; 3(10):1259-63.
        View in: PubMed
      36. Painter PL, Hector L, Ray K, Lynes L, Paul SM, Dodd M, Tomlanovich SL, Ascher NL. Effects of exercise training on coronary heart disease risk factors in renal transplant recipients. Am J Kidney Dis. 2003 Aug; 42(2):362-9.
        View in: PubMed
      37. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003 Jul 27; 76(2):370-5.
        View in: PubMed
      38. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, Ascher NL, Roberts JP. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl. 2003 Jul; 9(7):684-92.
        View in: PubMed
      39. Ascher NL. What's new in general surgery: transplantation. J Am Coll Surg. 2003 May; 196(5):778-83.
        View in: PubMed
      40. Ascher NL. Analysis of research projects in living donor organ transplantation. Transplant Proc. 2003 May; 35(3):907-8.
        View in: PubMed
      41. Niemann CU, Roberts JP, Ascher NL, Yost CS. Intraoperative hemodynamics and liver function in adult-to-adult living liver donors. Liver Transpl. 2002 Dec; 8(12):1126-32.
        View in: PubMed
      42. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002 Oct; 8(10):873-83.
        View in: PubMed
      43. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002 Sep; 8(9):765-74.
        View in: PubMed
      44. Toyoki Y, Renz JF, Mudge C, Ascher NL, Roberts JP, Rosenthal P. Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors. Pediatr Transplant. 2002 Aug; 6(4):301-7.
        View in: PubMed
      45. Painter PL, Hector L, Ray K, Lynes L, Dibble S, Paul SM, Tomlanovich SL, Ascher NL. A randomized trial of exercise training after renal transplantation. Transplantation. 2002 Jul 15; 74(1):42-8.
        View in: PubMed
      46. Diaz GC, Renz JF, Mudge C, Roberts JP, Ascher NL, Emond JC, Rosenthal P. Donor health assessment after living-donor liver transplantation. Ann Surg. 2002 Jul; 236(1):120-6.
        View in: PubMed
      47. Renz JF, Ascher NL. Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence. World J Surg. 2002 Feb; 26(2):247-56.
        View in: PubMed
      48. Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP, Ascher NL, Emond JC. Posttransplantation growth in pediatric liver recipients. Liver Transpl. 2001 Dec; 7(12):1040-55.
        View in: PubMed
      49. Stock P, Roland M, Carlson L, Freise C, Hirose R, Terrault N, Frassetto L, Coates T, Roberts J, Ascher N. Solid organ transplantation in HIV-positive patients. Transplant Proc. 2001 Nov-Dec; 33(7-8):3646-8.
        View in: PubMed
      50. Foster RD, Ascher NL, McCalmont TH, Neipp M, Anthony JP, Mathes SJ. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers. Transplantation. 2001 Sep 15; 72(5):791-7.
        View in: PubMed
      51. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001 Jun; 33(6):1394-403.
        View in: PubMed
      52. Koh BY, Rosenthal P, Medeiros LJ, Osorio RW, Roberts JP, Ascher NL, Gelb AB. Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation. Arch Pathol Lab Med. 2001 Mar; 125(3):337-43.
        View in: PubMed
      53. Painter P, Krasnoff J, Paul SM, Ascher NL. Physical activity and health-related quality of life in liver transplant recipients. Liver Transpl. 2001 Mar; 7(3):213-9.
        View in: PubMed
      54. Ascher NL. Immunosuppressant substitutes in liver transplantation. Lancet. 2001 Feb 24; 357(9256):571-2.
        View in: PubMed
      55. Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant. 2000 Dec; 14(6):550-4.
        View in: PubMed
      56. Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Liver Transpl. 2000 Nov; 6(6):734-40.
        View in: PubMed
      57. Reichert PR, Renz JF, D'Albuquerque LA, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: a clinicopathologic study. Ann Surg. 2000 Nov; 232(5):658-64.
        View in: PubMed
      58. Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE. Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg. 2000 Sep; 135(9):1016-9; discussion 1019-20.
        View in: PubMed
      59. Kang SM, Braat D, Schneider DB, O'Rourke RW, Lin Z, Ascher NL, Dichek DA, Baekkeskov S, Stock PG. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants. Transplantation. 2000 May 15; 69(9):1813-7.
        View in: PubMed
      60. O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, Baekkeskov S, Stock PG. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation. 2000 Apr 15; 69(7):1440-6.
        View in: PubMed
      61. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, Córdoba J, Herola A, Ascher N, Mir J, Berenguer J, Wright TL. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol. 2000 Apr; 32(4):673-84.
        View in: PubMed
      62. O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Clin Transplant. 2000 Apr; 14(2):167-73.
        View in: PubMed
      63. Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation. 2000 Jan 27; 69(2):307-11.
        View in: PubMed
      64. Narumi S, Hakamada K, Sasaki M, Freise CE, Stock PG, Roberts JP, Ascher NL. Liver transplantation for autoimmune hepatitis: rejection and recurrence. Transplant Proc. 1999 Aug; 31(5):1955-6.
        View in: PubMed
      65. Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, Linna TJ, Roberts JP. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. Transplantation. 1999 Mar 15; 67(5):707-12.
        View in: PubMed
      66. Renz JF, Lightdale J, Mudge C, Bacchetti P, Watson J, Ascher NL, Emond JC, Rosenthal P, Roberts JP. Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients. Liver Transpl Surg. 1999 Mar; 5(2):136-43.
        View in: PubMed
      67. Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation. 1999 Feb 27; 67(4):510-3.
        View in: PubMed
      68. Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL. Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation. Clin Transplant. 1998 Dec; 12(6):508-10.
        View in: PubMed
      69. Foster RD, Fan L, Neipp M, Kaufman C, McCalmont T, Ascher N, Ildstad S, Anthony JP, Niepp M. Donor-specific tolerance induction in composite tissue allografts. Am J Surg. 1998 Nov; 176(5):418-21.
        View in: PubMed
      70. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis after liver transplantation: the role of the known and unknown viruses. Liver Transpl Surg. 1998 Nov; 4(6):461-8.
        View in: PubMed
      71. Kita Y, Lake JR, Ferrell LD, Mori M, Roberts JP, Kakizoe S, Kiyosawa K, Tanaka E, Shiga J, Takikawa H, Inoue Y, Ohtake T, Ohtomo K, Yotsuyanagi H, Oka T, Harihara Y, Takayama T, Kubota K, Kawarasaki H, Hashikura Y, Kawasaki S, Ascher NL, Makuuchi M. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case. Transplant Proc. 1998 Nov; 30(7):3321-3.
        View in: PubMed
      72. Reichert PR, Renz JF, Rosenthal P, Bacchetti P, Lim RC, Roberts JP, Ascher NL, Emond JC. Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg. 1998 Sep; 4(5):343-9.
        View in: PubMed
      73. Lightdale JR, Mudge CL, Ascher NL, Rosenthal P. The role of pediatricians in the care of children with liver transplants. Arch Pediatr Adolesc Med. 1998 Aug; 152(8):797-802.
        View in: PubMed
      74. Terrault NA, Zhou S, McCory RW, Pruett TL, Lake JR, Roberts JP, Ascher NL, Wright TL. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology. 1998 Aug; 28(2):555-61.
        View in: PubMed
      75. Ascher NL. Tolerance induction using bone marrow transplantation. Liver Transpl Surg. 1998 Jul; 4(4):335-6.
        View in: PubMed
      76. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation. 1998 Apr 27; 65(8):1053-60.
        View in: PubMed
      77. Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP. Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine. Transplantation. 1998 Apr 15; 65(7):995-7.
        View in: PubMed
      78. Brown RS, Lake JR, Ascher NL, Emond JC, Roberts JP. Predictors of the cost of liver transplantation. Liver Transpl Surg. 1998 Mar; 4(2):170-6.
        View in: PubMed
      79. Ascher NL. Progress in transgenic pigs for xenotransplantation. Liver Transpl Surg. 1998 Mar; 4(2):180-1.
        View in: PubMed
      80. Kang SM, Lin Z, Ascher NL, Stock PG. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection. Transplant Proc. 1998 Mar; 30(2):538.
        View in: PubMed
      81. Kaufman DB, Ascher NL. Quo vadis, my transplant fellow: a discussion of transplant surgery fellowship training activity in the United States and Canada: 1991-1997. Education Committee of the American Society of Transplant Surgeons. Transplantation. 1998 Jan 27; 65(2):269-72.
        View in: PubMed
      82. Ascher NL. Interleukin-2 receptor antibody therapy. Liver Transpl Surg. 1997 Nov; 3(6):643-4.
        View in: PubMed
      83. Rosenthal P, Emond JC, Heyman MB, Snyder J, Roberts J, Ascher N, Ferrell L. Pathological changes in yearly protocol liver biopsy specimens from healthy pediatric liver recipients. Liver Transpl Surg. 1997 Nov; 3(6):559-62.
        View in: PubMed
      84. Brown RS, Ascher NL, Lake JR, Emond JC, Bacchetti P, Randall HB, Roberts JP. The impact of surgical complications after liver transplantation on resource utilization. Arch Surg. 1997 Oct; 132(10):1098-103.
        View in: PubMed
      85. Renz JF, Rosenthal P, Roberts JP, Ascher NL, Emond JC. Planned exploration of pediatric liver transplant recipients reduces posttransplant morbidity and lowers length of hospitalization. Arch Surg. 1997 Sep; 132(9):950-5; discussion 955-6.
        View in: PubMed
      86. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, Terrault N, Roberts J, Ascher N, Wright T, Lake J. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation. 1997 Aug 15; 64(3):410-4.
        View in: PubMed
      87. Rosenthal P, Roberts JP, Ascher NL, Emond JC. Auxiliary liver transplant in fulminant failure. Pediatrics. 1997 Aug; 100(2):E10.
        View in: PubMed
      88. Omura T, Nakagawa T, Randall HB, Lin Z, Huey M, Ascher NL, Emond JC. Increased immune responses to regenerating partial liver grafts in the rat. J Surg Res. 1997 Jun; 70(1):34-40.
        View in: PubMed
      89. Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, Yun AJ, Viele M, Lake JR, Roberts JP, Ascher NL, Wright TL. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology. 1997 May; 25(5):1266-70.
        View in: PubMed
      90. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR, Wiesner RH, Zetterman RK. A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. Transplantation. 1997 Apr 27; 63(8):1074-9.
        View in: PubMed
      91. Ascher NL. The role of the host immune state in recurrent hepatitis C. Liver Transpl Surg. 1997 Mar; 3(2):179-80.
        View in: PubMed
      92. Reiser M, Terrault N, Nelson DR, Mizokami M, Ferrell L, Lake JR, Roberts JP, Ascher NL, Wright TL, Lau JY. Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection. Transplantation. 1997 Feb 27; 63(4):609-12.
        View in: PubMed
      93. Orloff SL, Hirose R, Lin Z, Narumi S, Stock PG, Ascher NL. Clonal deletion is one mechanism responsible for tolerance in mixed hematopoietic chimeras. Transplant Proc. 1997 Feb-Mar; 29(1-2):1198-200.
        View in: PubMed
      94. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JY, Lake JR, Roberts JR, Ascher NL, Ferrell L, Wright TL. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 1996 Dec; 111(6):1569-75.
        View in: PubMed
      95. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology. 1996 Dec; 24(6):1327-33.
        View in: PubMed
      96. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology. 1996 Nov; 24(5):1041-6.
        View in: PubMed
      97. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lake JR, Ascher NL. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg. 1996 Oct; 224(4):544-52; discussion 552-4.
        View in: PubMed
      98. Kuang AA, Renz JF, Ferrell LD, Ring EJ, Rosenthal P, Lim RC, Roberts JP, Ascher NL, Emond JC. Failure patterns of cryopreserved vein grafts in liver transplantation. Transplantation. 1996 Sep 27; 62(6):742-7.
        View in: PubMed
      99. Renz JF, Lin Z, de Roos M, Dalal AA, Ascher NL. SCID mouse as a model for transplantation studies. J Surg Res. 1996 Sep; 65(1):34-41.
        View in: PubMed
      100. Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL. Liver transplantation improves survival of rats bearing hepatoma-3924A. J Surg Res. 1996 Sep; 65(1):59-62.
        View in: PubMed
      101. Freise CE, Liu T, Ascher NL, Roberts JP. Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma. J Surg Res. 1996 Aug; 64(2):198-202.
        View in: PubMed
      102. Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC. Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg. 1996 Aug; 131(8):887-92; discussion 892-3.
        View in: PubMed
      103. Emond JC, Stock P, Roberts JP, Ascher NL. Strategies for tolerance induction: potential applications in living donor liver transplantation. Transplant Proc. 1996 Aug; 28(4):2371-4.
        View in: PubMed
      104. Emond JC, Rosenthal P, Roberts JP, Stock P, Kelley S, Gregory G, Lim RC, Ascher NL. Living related donor liver transplantation: the UCSF experience. Transplant Proc. 1996 Aug; 28(4):2375-7.
        View in: PubMed
      105. Omura T, Ascher NL, Emond JC. Fifty-percent partial liver transplantation in the rat. Transplantation. 1996 Jul 27; 62(2):292-3.
        View in: PubMed
      106. Ascher NL. Expanding the immunosuppressive repertoire. Liver Transpl Surg. 1996 Jul; 2(4):304-5.
        View in: PubMed
      107. Ascher NL. Advances in biliary reconstruction after liver transplantation. Liver Transpl Surg. 1996 May; 2(3):238-9.
        View in: PubMed
      108. Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg. 1996 Mar; 2(2):132-8.
        View in: PubMed
      109. Gish RG, Ascher NL. Transmission of hepatitis B virus through allotransplantation. Liver Transpl Surg. 1996 Mar; 2(2):161-4.
        View in: PubMed
      110. Ascher NL. United Network for Organ Sharing center-specific data: our report card. Liver Transpl Surg. 1996 Mar; 2(2):168-9.
        View in: PubMed
      111. Brown RS, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 1996 Feb 27; 61(4):666-9.
        View in: PubMed
      112. Randall HB, Wachs ME, Somberg KA, Lake JR, Emond JC, Ascher NL, Roberts JP. The use of the T tube after orthotopic liver transplantation. Transplantation. 1996 Jan 27; 61(2):258-61.
        View in: PubMed
      113. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR. Cryoglobulinemia presenting after liver transplantation. Gastroenterology. 1996 Jan; 110(1):265-70.
        View in: PubMed
      114. Ascher NL. Hepatitis C dilemma? Liver Transpl Surg. 1996 Jan; 2(1):67-8.
        View in: PubMed
      115. Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto IK, Dinello RK, et al. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol. 1995 Dec; 104(6):673-9.
        View in: PubMed
      116. Ferrell LD, Lee R, Brixko C, Bass NM, Lake JR, Roberts JP, Ascher N, Rabkin J. Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients. Transplantation. 1995 Nov 15; 60(9):926-33.
        View in: PubMed
      117. Freise CE, Liu T, Osorio RW, Ferrell L, Ascher NL, Roberts JP. Increased efficacy of CSA following rearterialization in the rat OLTX model. J Surg Res. 1995 Oct; 59(4):493-6.
        View in: PubMed
      118. Detre KM, Lombardero M, Belle S, Beringer K, Breen T, Daily OP, Ascher NL. Influence of donor age on graft survival after liver transplantation--United Network for Organ Sharing Registry. Liver Transpl Surg. 1995 Sep; 1(5):311-9.
        View in: PubMed
      119. Ascher NL. Issues in xenotransplantation. Liver Transpl Surg. 1995 Sep; 1(5):320-1.
        View in: PubMed
      120. Deschler DG, Osorio R, Ascher NL, Lee KC. Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression. Arch Otolaryngol Head Neck Surg. 1995 Sep; 121(9):1037-41.
        View in: PubMed
      121. Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC. Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma. Arch Surg. 1995 Aug; 130(8):824-30; discussion 830-1.
        View in: PubMed
      122. Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology. 1995 Aug; 22(2):451-7.
        View in: PubMed
      123. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg. 1995 Jul; 1(4):242-8.
        View in: PubMed
      124. Ascher NL. Amelioration of acute GVHD disease and reestablishment of tolerance by short term treatment with anti TCR antibody. Liver Transpl Surg. 1995 Jul; 1(4):257-8.
        View in: PubMed
      125. Ascher NL. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Liver Transpl Surg. 1995 Jul; 1(4):256-7.
        View in: PubMed
      126. Wacher VJ, Liu T, Roberts JP, Ascher NL, Benet LZ. Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals. Biopharm Drug Dispos. 1995 May; 16(4):303-12.
        View in: PubMed
      127. LaBerge JM, Somberg KA, Lake JR, Gordon RL, Kerlan RK, Ascher NL, Roberts JP, Simor MM, Doherty CA, Hahn J, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995 Apr; 108(4):1143-51.
        View in: PubMed
      128. Ascher NL. Hepatocyte transplantation. Liver Transpl Surg. 1995 Mar; 1(2):139-42.
        View in: PubMed
      129. McDiarmid SV, Busuttil RW, Ascher NL, Burdick J, D'Alessandro AM, Esquivel C, Kalayoglu M, Klein AS, Marsh JW, Miller CM, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation. 1995 Feb 27; 59(4):530-6.
        View in: PubMed
      130. Somberg KA, Lombardero MS, Lawlor SM, Ascher NL, Lake JR. Impact of transjugular intrahepatic portosystemic shunts on liver transplantation: a controlled analysis. NIDDK Liver Transplantation Database. Transplant Proc. 1995 Feb; 27(1):1248-9.
        View in: PubMed
      131. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation. 1995 Jan 27; 59(2):230-4.
        View in: PubMed
      132. Ascher NL. Microchimerism in organ transplantation. Liver Transpl Surg. 1995 Jan; 1(1):43-6.
        View in: PubMed
      133. Ascher NL. Immunosuppressive therapy in liver transplantation: principles and practice. Prog Liver Dis. 1995; 13:381-95.
        View in: PubMed
      134. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995 Jan; 21(1):240-52.
        View in: PubMed
      135. Gross CR, Savik SK, Ascher NL, Gordon RD, Klintmalm GB, Payne W, Shaw BW, Strasburg K, Parker A, Wiesner RH, et al. Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients. Transplant Proc. 1994 Oct; 26(5):2686-90.
        View in: PubMed
      136. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, Ascher N, Roberts J, Wilber J, Sheridan P, Urdea M. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology. 1994 Oct; 20(4 Pt 1):773-9.
        View in: PubMed
      137. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology. 1994 Jul; 20(1 Pt 1):105-10.
        View in: PubMed
      138. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology. 1994 Jul; 20(1 Pt 2):24S-27S.
        View in: PubMed
      139. Osorio RW, Ascher NL, Melzer JS, Stock PG. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice. Transplant Proc. 1994 Apr; 26(2):752.
        View in: PubMed
      140. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994 Apr; 106(4):994-9.
        View in: PubMed
      141. Osorio RW, Ascher NL, Melzer JS, Stock PG. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody. Transplant Proc. 1994 Apr; 26(2):749.
        View in: PubMed
      142. Osorio RW, Ascher NL, Stock PG. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Transplantation. 1994 Mar 27; 57(6):783-8.
        View in: PubMed
      143. Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP. The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome. Transplantation. 1994 Mar 27; 57(6):928-32.
        View in: PubMed
      144. Chazouillères O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet. 1994 Jan 15; 343(8890):142-6.
        View in: PubMed
      145. Ascher NL. Liver transplantation and the Najarian footprint. Am J Surg. 1993 Nov; 166(5):509-11.
        View in: PubMed
      146. Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes. 1993 Oct; 42(10):1520-7.
        View in: PubMed
      147. Roberts JP, Lake JR, Hebert M, Nikolai B, Ascher NL, Ferrell LD. Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation. 1993 Oct; 56(4):1021-3.
        View in: PubMed
      148. Evans RW, Manninen DL, Dong FB, Ascher NL, Frist WH, Hansen JA, Kirklin JK, Perkins JD, Pirsch JD, Sanfilippo FP. Immunosuppressive therapy as a determinant of transplantation outcomes. Transplantation. 1993 Jun; 55(6):1297-305.
        View in: PubMed
      149. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg. 1993 Jun; 128(6):677-82.
        View in: PubMed
      150. Krams SM, Ascher NL, Martinez OM. New immunologic insights into mechanisms of allograft rejection. Gastroenterol Clin North Am. 1993 Jun; 22(2):381-400.
        View in: PubMed
      151. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993 May; 187(2):413-20.
        View in: PubMed
      152. Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP. Nonoperative management of biliary leaks after orthotopic liver transplantation. Transplantation. 1993 May; 55(5):1074-7.
        View in: PubMed
      153. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation. 1993 May; 55(5):1159-66.
        View in: PubMed
      154. Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology. 1993 Apr; 17(4):593-8.
        View in: PubMed
      155. Freise CE, Hebert M, Osorio RW, Nikolai B, Lake JR, Kauffman RS, Ascher NL, Roberts JP. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Transplant Proc. 1993 Apr; 25(2):1758-9.
        View in: PubMed
      156. Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N. Hepatitis C and B in liver transplantation. Transplant Proc. 1993 Apr; 25(2):2006-9.
        View in: PubMed
      157. Ascher NL. Immunosuppression and rejection in liver transplantation. Transplant Proc. 1993 Apr; 25(2):1744-5.
        View in: PubMed
      158. Lake JR, Ring E, LaBerge J, Gordon R, Roberts J, Ascher N. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc. 1993 Apr; 25(2):1766-7.
        View in: PubMed
      159. Martinez OM, Ascher NL, Ferrell L, Villanueva J, Lake J, Roberts JP, Krams SM. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation. 1993 Apr; 55(4):909-18.
        View in: PubMed
      160. Osorio RW, Ascher NL, Jaenisch R, Natuzzi ES, Freise CE, Roberts JP, Stock PG. Isolation of functional MHC class I-deficient islet cells. Transplant Proc. 1993 Feb; 25(1 Pt 2):968-9.
        View in: PubMed
      161. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):679-88.
        View in: PubMed
      162. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):641-3.
        View in: PubMed
      163. Krams SM, Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL. T-cell receptor-V alpha gene use in sequential liver allograft biopsies. Transplant Proc. 1993 Feb; 25(1 Pt 1):84-5.
        View in: PubMed
      164. Orians CE, Evans RW, Ascher NL. Estimates of organ-specific donor availability for the United States. Transplant Proc. 1993 Feb; 25(1 Pt 2):1541-2.
        View in: PubMed
      165. Stock PG, Ascher NL, Osorio RW, Tomlanovich S, Lake JR, Nikolai B, Freise C, Roberts JP. Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. Transplant Proc. 1993 Feb; 25(1 Pt 1):675-6.
        View in: PubMed
      166. Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J, et al. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Transplant Proc. 1993 Feb; 25(1 Pt 1):635-7.
        View in: PubMed
      167. Martinez OM, Krams SM, Villanueva JC, Ferrell L, Lake J, Roberts JP, Ascher NL. Intragraft eosinophilia and interleukin-5 mRNA accompany liver allograft rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):126-7.
        View in: PubMed
      168. Klintmalm GB, Ascher NL, Busuttil RW, Deierhoi M, Gonwa TA, Kauffman R, McDiarmid S, Poplawski S, Sollinger H, Roberts J. RS-61443 for treatment-resistant human liver rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):697.
        View in: PubMed
      169. Osorio RW, Freise CE, Ascher NL, Roberts JP, Avery M, Lake JR. Orthotopic liver transplantation for end-stage alcoholic liver disease. Transplant Proc. 1993 Feb; 25(1 Pt 2):1133-4.
        View in: PubMed
      170. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation at the University of California, San Francisco. Clin Transpl. 1993; 175-7.
        View in: PubMed
      171. Ferrell L, Wright T, Lake J, Roberts J, Ascher N. Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Hepatology. 1992 Dec; 16(6):1372-81.
        View in: PubMed
      172. Ferrell L, Bass N, Roberts J, Ascher N. Lipopeliosis: fat induced sinusoidal dilatation in transplanted liver mimicking peliosis hepatis. J Clin Pathol. 1992 Dec; 45(12):1109-10.
        View in: PubMed
      173. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology. 1992 Oct; 16(4):865-76.
        View in: PubMed
      174. Prager MC, Cauldwell CA, Ascher NL, Roberts JP, Wolfe CL. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology. 1992 Aug; 77(2):375-8.
        View in: PubMed
      175. LaBerge JM, Ring EJ, Lake JR, Ferrell LD, Doherty MM, Gordon RL, Roberts JP, Peltzer MY, Ascher NL. Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients. J Vasc Surg. 1992 Aug; 16(2):258-67.
        View in: PubMed
      176. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, Ascher NL, Roberts JP, Scharschmidt BF, Lake JR. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992 Jul; 16(1):1-7.
        View in: PubMed
      177. Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP. A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation. 1992 Jul; 54(1):179-80.
        View in: PubMed
      178. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul; 103(1):317-22.
        View in: PubMed
      179. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, Lake J, Roberts J, Ascher NL. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 1992 Apr 18; 339(8799):952-5.
        View in: PubMed
      180. Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes. Transplantation. 1992 Apr; 53(4):863-8.
        View in: PubMed
      181. Bumgardner GL, Chen S, Almond PS, Bach FH, Ascher NL, Matas AJ. Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts. Transplantation. 1992 Apr; 53(4):857-62.
        View in: PubMed
      182. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, Ascher NL. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med. 1992 Feb 15; 116(4):304-9.
        View in: PubMed
      183. Lake JR, Roberts JP, Ascher NL. Maintenance immunosuppression after liver transplantation. Semin Liver Dis. 1992 Feb; 12(1):73-9.
        View in: PubMed
      184. Martinez OM, Krams SM, Sterneck M, Villanueva JC, Falco DA, Ferrell LD, Lake J, Roberts JP, Ascher NL. Intragraft cytokine profile during human liver allograft rejection. Transplantation. 1992 Feb; 53(2):449-56.
        View in: PubMed
      185. Evans RW, Orians CE, Ascher NL. The potential supply of organ donors. An assessment of the efficacy of organ procurement efforts in the United States. JAMA. 1992 Jan 8; 267(2):239-46.
        View in: PubMed
      186. Prager MC, Johnson KL, Ascher NL, Roberts JP. Anesthetic care of patients with Crigler-Najjar syndrome. Anesth Analg. 1992 Jan; 74(1):162-4.
        View in: PubMed
      187. Hebert MF, Ascher NL, Lake JR, Roberts JP. Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. Transplant Proc. 1991 Dec; 23(6):3109-10.
        View in: PubMed
      188. Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc. 1991 Dec; 23(6):3173-4.
        View in: PubMed
      189. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL, Lake JR, Roberts JP, Ascher NL. Histopathologic study of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 1991 Nov; 2(4):549-56.
        View in: PubMed
      190. Sterneck M, Wiesner R, Ascher N, Roberts J, Ferrell L, Ludwig J, Lake J. Azathioprine hepatotoxicity after liver transplantation. Hepatology. 1991 Nov; 14(5):806-10.
        View in: PubMed
      191. Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE. Evidence for direct and indirect pathways in the generation of the alloimmune response against pancreatic islets. Transplantation. 1991 Oct; 52(4):704-9.
        View in: PubMed
      192. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, Lynch R, Ferrell L, Wright T. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology. 1991 Aug; 14(2):274-81.
        View in: PubMed
      193. Freise CE, Clemmings S, Clemens LE, Alan T, Ashby T, Ashby E, Burke EC, Roberts JP, Ascher NL. Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model. Transplantation. 1991 Aug; 52(2):318-25.
        View in: PubMed
      194. Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med. 1991 Jul 15; 115(2):111-2.
        View in: PubMed
      195. Freese DK, Tuchman M, Schwarzenberg SJ, Sharp HL, Rank JM, Bloomer JR, Ascher NL, Payne WD. Early liver transplantation is indicated for tyrosinemia type I. J Pediatr Gastroenterol Nutr. 1991 Jul; 13(1):10-5.
        View in: PubMed
      196. Roberts JP, Ring E, Lake JR, Sterneck M, Ascher NL. Intrahepatic portocaval shunt for variceal hemorrhage prior to liver transplantation. Transplantation. 1991 Jul; 52(1):160-2.
        View in: PubMed
      197. Aldape KD, Fox HS, Roberts JP, Ascher NL, Lake JR, Rowley HA. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol. 1991 Apr; 95(4):499-502.
        View in: PubMed
      198. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991 Feb 15; 114(4):282-4.
        View in: PubMed
      199. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1504-5.
        View in: PubMed
      200. Cohen N, Roberts J, Gumbert M, Birnbaum J, Lim VL, Falco D, Ascher N, Garovoy MR. Comparison of ELISA and a flow cytometric method in the daily monitoring of soluble interleukin 2 receptors in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1426-7.
        View in: PubMed
      201. Clemmings SM, Alan TJ, Bumgardner GL, Ascher NL. Lack of class II antigen expression on hepatocytes profoundly affects CTL development in vitro and in vivo. Transplant Proc. 1991 Feb; 23(1 Pt 1):817-8.
        View in: PubMed
      202. Freise CE, Hong K, Clemens LE, Papahadjopoulos D, Burke E, Martinez O, Lake J, Ascher NL, Roberts JP. Characterization of a cyclosporine-containing liposome. Transplant Proc. 1991 Feb; 23(1 Pt 1):473-4.
        View in: PubMed
      203. Martinez OM, Burke EC, Alan TJ, Ascher NL. Allogeneic hepatocytes stimulate the production of immunoregulatory molecules in mixed lymphocyte hepatocyte cultures. Transplant Proc. 1991 Feb; 23(1 Pt 1):805-6.
        View in: PubMed
      204. Cohen N, Gumbert M, Birnbaum J, Lim VL, Falco D, Ascher N, Roberts J, Garovoy MR. An improved method for the detection of soluble interleukin 2 receptors in liver transplant recipients by flow cytometry. Transplantation. 1991 Feb; 51(2):417-21.
        View in: PubMed
      205. Burke EC, Martinez OM, Freise CE, McVicar J, Roberts JP, Ascher NL. MHC expression on human hepatocytes before and after isolation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1428-9.
        View in: PubMed
      206. Stock PG, Ascher NL, Chen S, Field J, Bach FH, Sutherland DE. The alloimmune response against pancreatic islets is generated by both direct and indirect pathways. Transplant Proc. 1991 Feb; 23(1 Pt 1):819-20.
        View in: PubMed
      207. Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1498-500.
        View in: PubMed
      208. Lavine JE, Lake JR, Ascher NL, Ferrell LD, Ganem D, Wright TL. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation. Gastroenterology. 1991 Jan; 100(1):263-7.
        View in: PubMed
      209. Olcott EW, Ring EJ, Roberts JP, Ascher NL, Lake JR, Gordon RL. Percutaneous transhepatic portal vein angioplasty and stent placement after liver transplantation: early experience. J Vasc Interv Radiol. 1990 Nov; 1(1):17-22.
        View in: PubMed
      210. Roberts JP, Hughes L, Goldstone J, Ascher NL. Examination of vascular anastomoses during liver transplantation by intraoperative Doppler duplex scanning. Clin Transplant. 1990 Aug; 4(4):206-9.
        View in: PubMed
      211. Bumgardner GL, Chen S, Almond SP, Ascher NL, Payne WD, Matas AJ. Role of macrophages in the immune response to hepatocytes. J Surg Res. 1990 Jun; 48(6):568-72.
        View in: PubMed
      212. Ostroff JW, Roberts JP, Gordon RL, Ring EJ, Ascher NL. The management of T tube leaks in orthotopic liver transplant recipients with endoscopically placed nasobiliary catheters. Transplantation. 1990 May; 49(5):922-4.
        View in: PubMed
      213. Pinson CW, Daya MR, Benner KG, Norton RL, Deveney KE, Ascher NL, Roberts JP, Lake JR, Kurkchubasche AG, Ragsdale JW, et al. Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg. 1990 May; 159(5):493-9.
        View in: PubMed
      214. Stock PG, Ascher NL, Chen S, Bumgardner G, Field MJ, Sutherland DE. The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes. Transplant Proc. 1990 Apr; 22(2):841-3.
        View in: PubMed
      215. Bumgardner GL, Matas AJ, Chen S, Cahill D, Cunningham TR, Payne WD, Bach FH, Ascher NL. Comparison of in vivo and in vitro immune response to purified hepatocytes. Transplantation. 1990 Feb; 49(2):429-36.
        View in: PubMed
      216. Prager MC, Gregory GA, Ascher NL, Roberts JP. Massive venous air embolism during orthotopic liver transplantation. Anesthesiology. 1990 Jan; 72(1):198-200.
        View in: PubMed
      217. Gruber SA, Hrushesky WJ, Canafax DM, Cipolle RJ, Burke BA, Matas AJ, Ascher NL, Simmons RL. Local prednisolone infusion of canine renal allografts. Transplantation. 1989 Dec; 48(6):1072-5.
        View in: PubMed
      218. Gruber SA, Canafax DM, Erdmann GR, Cipolle RJ, Burke BA, Rabatin JT, Hynes PE, Gould FH, Heil JE, Ascher NL, et al. The pharmacokinetic advantage of local 6-mercaptopurine infusion in a canine renal transplant model. Transplantation. 1989 Dec; 48(6):928-35.
        View in: PubMed
      219. Roberts JP, Ascher NL, Fryd DS, Hunter DW, Dunn DL, Payne WD, Sutherland DE, Castaneda-Zuniga W, Najarian JS. Transplant renal artery stenosis. Transplantation. 1989 Oct; 48(4):580-3.
        View in: PubMed
      220. Schwarzenberg SJ, Freese DK, Payne WD, Ascher NL, Sharp HL. Gastric bezoar after hepatic transplantation. J Pediatr Gastroenterol Nutr. 1989 Jul; 9(1):119-22.
        View in: PubMed
      221. Bloomer JR, Weimer MK, Bossenmaier IC, Snover DC, Payne WD, Ascher NL. Liver transplantation in a patient with protoporphyria. Gastroenterology. 1989 Jul; 97(1):188-94.
        View in: PubMed
      222. Estrin JA, Belani KG, Ascher NL, Lura D, Payne W, Najarian JS. Hemodynamic changes on clamping and unclamping of major vessels during liver transplantation. Transplant Proc. 1989 Jun; 21(3):3500-5.
        View in: PubMed
      223. Ascher NL. Selection criteria for liver transplantation donors. Transplant Proc. 1989 Jun; 21(3):3482-3.
        View in: PubMed
      224. Stock PG, Ascher NL, Chen S, Bumgardner GL, Field MJ, Sutherland DE. Modulation of MHC class I antigen decreases pancreatic islet immunogenicity. J Surg Res. 1989 Apr; 46(4):317-21.
        View in: PubMed
      225. Letourneau JG, Hunter DW, Ascher NL, Roberts JP, Payne WD, Thompson WM, Najarian JS, Castaneda-Zuniga WR, Day DL. Biliary complications after liver transplantation in children. Radiology. 1989 Mar; 170(3 Pt 2):1095-9.
        View in: PubMed
      226. Fasola CG, Fryd DS, Fischel RJ, Ascher NL, Payne WD, Najarian JS. Adult kidney retransplantation: evolution of treatment and results over 25 years at the University of Minnesota. Transplant Proc. 1989 Feb; 21(1 Pt 2):2165-7.
        View in: PubMed
      227. Bumgardner GL, Mauer SM, Ascher NL, Payne WD, Dunn DL, Fryd DS, Sutherland DE, Simmons RL, Najarian JS. Long-term outcome of renal transplantation in patients with systemic lupus erythematosus. Transplant Proc. 1989 Feb; 21(1 Pt 2):2031-2.
        View in: PubMed
      228. Fischel RJ, Ascher NL, Payne WD, Freese DK, Stock P, Fasola C, Najarian JS. Pediatric liver transplantation across ABO blood group barriers. Transplant Proc. 1989 Feb; 21(1 Pt 2):2221-2.
        View in: PubMed
      229. Stock PG, Payne WD, Ascher NL, Roberts JP, Belani K, Estrin J, Najarian JS. Rapid infusion technique as a safe alternative to veno-venous bypass in orthotopic liver transplant (TX). Transplant Proc. 1989 Feb; 21(1 Pt 2):2322-5.
        View in: PubMed
      230. Bumgardner GL, Cahill DR, Chen S, Bach FH, Ascher NL. L3T4+,LyT2- and LyT2+,L3T4- T cells participate in the generation of allospecific cytotoxicity in response to MHC class I+ hepatocytes. Transplant Proc. 1989 Feb; 21(1 Pt 1):421-2.
        View in: PubMed
      231. Stock PG, Clemmings SM, Han D, Sutherland DE, Ascher NL. Frequency of precursor cytotoxic T lymphocytes correlates with outcome following heart-lung and pancreatic islet transplantation. Transplant Proc. 1989 Feb; 21(1 Pt 1):457-60.
        View in: PubMed
      232. Meloche M, Bumgardner G, Stock P, Chen S, Ascher NL, Sutherland DE. Comparative in vitro immunogenicity of cultured murine islets and hepatocytes. Transplant Proc. 1989 Feb; 21(1 Pt 3):2682-4.
        View in: PubMed
      233. Dehner LP, Snover DC, Sharp HL, Ascher N, Nakhleh R, Day DL. Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver. Hum Pathol. 1989 Feb; 20(2):149-58.
        View in: PubMed
      234. Bumgardner GL, Billiar T, So SK, Chen S, Dunn G, Payne W, Ascher NL. In vitro immunosuppressive effects of murine hepatocyte cytosol. Transplant Proc. 1989 Feb; 21(1 Pt 1):1154-5.
        View in: PubMed
      235. Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL. Factors influencing early survival after liver transplantation. Am J Surg. 1989 Feb; 157(2):215-9.
        View in: PubMed
      236. Chan GL, Erdmann GR, Gruber SA, Stock P, Chen S, Ascher NL, Canafax DM. Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine. Eur J Clin Pharmacol. 1989; 36(3):265-71.
        View in: PubMed
      237. Stock PG, Ascher NL, Platt JL, Kaufman DB, Chen S, Field MJ, Sutherland DE. Effect of immunodepletion of MHC class II-positive cells from pancreatic islets on generation of cytotoxic T-lymphocytes in mixed islet-lymphocyte coculture. Diabetes. 1989 Jan; 38 Suppl 1:157-60.
        View in: PubMed
      238. Bumgardner GL, Chen S, Hoffman R, Ascher NL. Responder T-cell subsets and antigenic stimulus in mixed lymphocyte-hepatocyte culture. Curr Surg. 1989 Jan-Feb; 46(1):20-3.
        View in: PubMed
      239. Bumgardner GL, Chen S, Hoffman R, Cahill DC, So SK, Platt J, Bach FH, Ascher NL. Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes. Transplantation. 1989 Jan; 47(1):163-70.
        View in: PubMed
      240. Stock PG, Meloche M, Ascher NL, Chen S, Bach FH, Sutherland DE. Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells. Diabetes. 1989 Jan; 38 Suppl 1:161-4.
        View in: PubMed
      241. Roberts JP, Forsmark C, Lake JR, Ascher NL. Liver transplantation today. Annu Rev Med. 1989; 40:287-303.
        View in: PubMed
      242. Gruber SA, Cipolle RJ, Canafax DM, Erdmann GR, Burke BA, Rabatin JT, Hynes PE, Ritz JA, Gould FH, Ascher NL, et al. An implantable pump for intrarenal infusion of immunosuppressants in a canine autotransplant model. Pharm Res. 1988 Dec; 5(12):781-5.
        View in: PubMed
      243. Ascher NL, Stock PG, Bumgardner GL, Payne WD, Najarian JS. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet. 1988 Dec; 167(6):474-84.
        View in: PubMed
      244. Burke GW, Ascher NL, Hunter D, Najarian JS. Orthotopic liver transplantation: nonoperative management of early, acute portal vein thrombosis. Surgery. 1988 Nov; 104(5):924-8.
        View in: PubMed
      245. Bumgardner GL, Mauer SM, Payne W, Dunn DL, Sutherland DE, Fryd DS, Ascher NL, Simmons RL, Najarian JS. Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation. 1988 Nov; 46(5):703-9.
        View in: PubMed
      246. Bumgardner GL, Stock PG, Payne WD, Najarian JS, Ascher NL. [Comparison of the results of liver transplantation in children and adults]. Chirurg. 1988 Aug; 59(8):526-35.
        View in: PubMed
      247. Stock PG, Ascher NL, Kaufman DB, Chen S, Meloche M, Field MJ, Sutherland DE. In vitro generated allospecific cytolytic T lymphocytes injure pancreatic islets. J Surg Res. 1988 Jul; 45(1):74-81.
        View in: PubMed
      248. Fischel RJ, Fischel H, Shatzel A, Lange WP, Cahill D, Gervais D, Ascher NL. Couette membrane filtration with constant shear stress. ASAIO Trans. 1988 Jul-Sep; 34(3):375-85.
        View in: PubMed
      249. Najarian JS, Migliori RJ, Simmons RL, Ascher NL, Payne WD, Dunn D, Sutherland DE, Fryd DS. Effects of HLA matching in cadaver renal transplants. Transplant Proc. 1988 Jun; 20(3 Suppl 3):249-56.
        View in: PubMed
      250. Kaufman DB, Sutherland DE, Fryd DS, Ascher NL, Simmons RL, Najarian JS. A single-center experience of renal transplantation in thirteen Jehovah's Witnesses. Transplantation. 1988 Jun; 45(6):1045-9.
        View in: PubMed
      251. Dalen K, Day DL, Ascher NL, Hunter DW, Thompson WM, Castaneda-Zuniga WR, Letourneau JG. Imaging of vascular complications after hepatic transplantation. AJR Am J Roentgenol. 1988 Jun; 150(6):1285-90.
        View in: PubMed
      252. Ford HR, Fryd DS, Canafax DM, Ascher NL, Dunn D, Sutherland DE, Najarian JS, Simmons RL. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine. Transplant Proc. 1988 Jun; 20(3 Suppl 3):8-12.
        View in: PubMed
      253. Gruber SA, Simmons RL, Najarian JS, Vercellotti G, Ascher NL, Dunn DL, Payne WD, Sutherland DE, Fryd DS. Erythrocytosis and thromboembolic complications after renal transplantation: results from a randomized trial of cyclosporine versus azathioprine-antilymphocyte globulin. Transplant Proc. 1988 Jun; 20(3 Suppl 3):948-50.
        View in: PubMed
      254. Stock P, Ascher N, Chen S, Field J, Platt J, Kaufman D, Sutherland D. Pancreatic islets generate allospecific cytolytic T lymphocytes in a mixed lymphocyte-islet culture. Curr Surg. 1988 May-Jun; 45(3):198-200.
        View in: PubMed
      255. Letourneau JG, Day DL, Hunter DW, Ascher NL, Najarian JS, Thompson WM, Castaneda-Zuniga WR. Biliary complications after liver transplantation in patients with preexisting sclerosing cholangitis. Radiology. 1988 May; 167(2):349-51.
        View in: PubMed
      256. Hoffman RA, Jordan ML, Ascher NL, Simmons RL. The contribution of natural killer cells to the allograft response. Transplant Proc. 1988 Apr; 20(2):186-8.
        View in: PubMed
      257. Ascher NL, Clemmings SM, Cahill DR, Hoffman RA. Lymphocyte traffic and distribution after sponge matrix allograft using limiting dilution analysis. Transplant Proc. 1988 Apr; 20(2):231-2.
        View in: PubMed
      258. Letourneau JG, Day DL, Ascher NL, Castaneda-Zuniga WR. Imaging of renal transplants. AJR Am J Roentgenol. 1988 Apr; 150(4):833-8.
        View in: PubMed
      259. Hoffman RA, Ascher NL, Jordan ML, Migliori RJ, Simmons RL. Characterization of natural killer activity in sponge matrix allografts. J Immunol. 1988 Mar 1; 140(5):1702-10.
        View in: PubMed
      260. Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years. Transplantation. 1988 Feb; 45(2):380-5.
        View in: PubMed
      261. Migliori RJ, Hoffman RA, Gruber SA, Debe EC, Ascher NL, Simmons RL. Failure of freshly inplanted alloantigen in vivo to attract circulating allosensitized lymphocytes. Transplantation. 1988 Feb; 45(2):452-8.
        View in: PubMed
      262. Gruber SA, Pescovitz MD, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Fryd DS. Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin. Transplantation. 1987 Dec; 44(6):775-8.
        View in: PubMed
      263. Stock PG, Sutherland DE, Fryd DS, Ascher NL, Payne W, Simmons RL, Najarian JS. ABO-compatible mismatching decreases 5-year actuarial graft survival after renal transplantation. Transplant Proc. 1987 Dec; 19(6):4522-4.
        View in: PubMed
      264. Stock P, Ascher N, Kaufman D, Sutherland D. Mixed islet-lymphocyte culture as a model for pancreatic islet immunogenicity and cell-mediated immune injury. Transplant Proc. 1987 Oct; 19(5):4345-6.
        View in: PubMed
      265. Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation. 1987 Sep; 44(3):376-81.
        View in: PubMed
      266. Gruber SA, Migliori RJ, Hoffman RA, Ascher NL, Simmons RL. Suppression of macrophage-mediated lymphocyte recruitment by local but not systemic steroids. Curr Surg. 1987 Sep-Oct; 44(5):406-8.
        View in: PubMed
      267. Stock PG, Ascher NL, Najarian JS. Pediatric liver transplantation using combination immunosuppressive therapy. Transplant Proc. 1987 Aug; 19(4):3303-8.
        View in: PubMed
      268. Platt JL, Ascher NL, Snover DC, So SK. Major histocompatibility complex class I antigens on hepatocytes in human liver grafts. Transplant Proc. 1987 Aug; 19(4 Suppl 3):66-7.
        View in: PubMed
      269. Letourneau JG, Day DL, Ascher NL, Snover DC, Steely JW, Crass JR, Najarian JS, Feinberg SB. Abdominal sonography after hepatic transplantation: results in 36 patients. AJR Am J Roentgenol. 1987 Aug; 149(2):299-303.
        View in: PubMed
      270. Day DL, Letourneau JG, Allan BT, Sharp HL, Ascher N, Dehner LP, Thompson WM. Hepatic regenerating nodules in hereditary tyrosinemia. AJR Am J Roentgenol. 1987 Aug; 149(2):391-3.
        View in: PubMed
      271. Bellani KG, Estrin JA, Ascher NL, Najarian JS, Bushman J, Buckley JJ. Reperfusion coagulopathy during human liver transplantation. Transplant Proc. 1987 Aug; 19(4 Suppl 3):71-2.
        View in: PubMed
      272. Letourneau JG, Day DL, Maile CW, Crass JR, Ascher NL, Frick MP. Liver allograft transplantation: postoperative CT findings. AJR Am J Roentgenol. 1987 Jun; 148(6):1099-103.
        View in: PubMed
      273. Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL. Hepatitis-associated aplastic anemia after liver transplantation. Transplantation. 1987 Apr; 43(4):595-7.
        View in: PubMed
      274. Sutherland DE, Fryd DS, Payne WD, Ascher N, Simmons RL, Najarian JS. Kidney transplantation in diabetic patients. Transplant Proc. 1987 Apr; 19(2 Suppl 2):90-4.
        View in: PubMed
      275. Letourneau JG, Day DL, Frick MP, Steely JW, Maile CW, Ascher NL, Feinberg SB. Ultrasound and computed tomographic evaluation in hepatic transplantation. Radiol Clin North Am. 1987 Mar; 25(2):323-31.
        View in: PubMed
      276. Tuchman M, Freese DK, Sharp HL, Ramnaraine ML, Ascher N, Bloomer JR. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation. J Pediatr. 1987 Mar; 110(3):399-403.
        View in: PubMed
      277. Najarian JS, So SK, Simmons RL, Mauer SM, Nevins TE, Sutherland DE, Ascher NL, Chavers BM, Payne WD, Fryd DS. First kidney transplants in children 5 years of age or younger. Transplant Proc. 1987 Feb; 19(1 Pt 3):2111-2.
        View in: PubMed
      278. Gruber SA, Pescovitz M, Simmons RL, Najarian JS, Ascher NL, Payne WD, Sutherland DE, Elick B, Fryd DS. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin. Transplant Proc. 1987 Feb; 19(1 Pt 2):1815-6.
        View in: PubMed
      279. Ascher NL, Evans RW. Designation of liver transplant centers in the United States. Transplant Proc. 1987 Feb; 19(1 Pt 3):2405.
        View in: PubMed
      280. Migliori RJ, Hoffman R, Debe E, Ascher NL, Simmons RL. In vivo macrophage-directed lymphocyte traffic requires macrophage activation. Transplant Proc. 1987 Feb; 19(1 Pt 1):338-41.
        View in: PubMed
      281. Ascher NL. Effector mechanisms in allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 1):57-60.
        View in: PubMed
      282. Pescovitz MD, Gruber SA, Ascher NL, Kruse LV, Najarian JS, Payne WD, Simmons RL, Sutherland DE, Fryd DS. Frequency of diabetes-related complications in renal allograft recipients prospectively randomized to cyclosporine or azathioprine. Transplant Proc. 1987 Feb; 19(1 Pt 2):1537-8.
        View in: PubMed
      283. Fryd D, Migliori RJ, Ascher NL, Payne W, Sutherland DE, Simmons R, Najarian JS. Can renal transplantation be done safely without prior dialysis therapy? Transplant Proc. 1987 Feb; 19(1 Pt 2):1557-8.
        View in: PubMed
      284. So SK, Wilkes LM, Platt JL, Ascher NL, Simmons RL. Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture. Transplant Proc. 1987 Feb; 19(1 Pt 1):251-2.
        View in: PubMed
      285. Migliori RJ, Simmons RL, Fryd D, Noreen H, Ascher NL, Sutherland DE, Payne W, Najarian JS. HLA-DR tissue typing may be ignored for first but not subsequent cadaver renal transplants. Transplant Proc. 1987 Feb; 19(1 Pt 1):689-90.
        View in: PubMed
      286. Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS, et al. Cox regression analysis of outcome risk factors in 519 renal allograft recipients. Transplant Proc. 1987 Feb; 19(1 Pt 3):1947-8.
        View in: PubMed
      287. So SK, Snover DC, Ascher NL, Platt JL. Class I major histocompatibility complex antigens are induced on hepatocytes in rejecting human liver grafts. Transplant Proc. 1987 Feb; 19(1 Pt 3):2464-5.
        View in: PubMed
      288. Hoffman RA, Jordan ML, Ascher NL, Simmons RL. The role of natural killer cells in the allograft response. Transplant Proc. 1987 Feb; 19(1 Pt 1):342-4.
        View in: PubMed
      289. Clemmings SM, Hoffman RA, Cahill DR, Simmons RL, Ascher NL. Compartmentalization and lymphocyte traffic after allograft challenge. Transplant Proc. 1987 Feb; 19(1 Pt 1):359-60.
        View in: PubMed
      290. Cahill DR, Hoffman RA, Clemmings SM, Simmons RL, Ascher NL. Cloned T cells do not require host H-2 restrictions to elicit delayed-type hypersensitivity. Transplant Proc. 1987 Feb; 19(1 Pt 1):410-1.
        View in: PubMed
      291. Stock P, Sutherland DE, Fryd DS, Ascher NL, Payne WD, Simmons RL, Najarian JS. Detrimental effect of ABO mismatching in renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):711-2.
        View in: PubMed
      292. Noreen HJ, van der Hagen E, Bach FH, Fryd D, Ascher N, Simmons RL, Najarian JS. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. Transplant Proc. 1987 Feb; 19(1 Pt 1):780-1.
        View in: PubMed
      293. Becker WK, Stock P, Fath JJ, Konstantinides FN, Ascher NL, Cerra FB. Plasma amino acid clearance predicts hepatic recovery after normothermic anoxia and cold preservation. Transplant Proc. 1987 Feb; 19(1 Pt 2):1331.
        View in: PubMed
      294. Stock PG, Estrin JA, Fryd DS, Payne WD, Belani KG, Elick BA, Najarian JS, Ascher NL. Prognostic perioperative factors predicting the outcome of liver transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2427-8.
        View in: PubMed
      295. St Cyr JA, Elick B, Freese D, Sharp H, Payne W, Bloomer J, Stock P, Snover D, Najarian JS, Ascher NL. Use of triple therapy and percutaneous needle biopsy to minimize graft failure following liver transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 3):2451-3.
        View in: PubMed
      296. Snover DC, Freese DK, Bloomer JR, Sharp HL, Ascher NL. An analysis of histological prognostic features of liver allograft rejection based on 270 serial biopsies. Transplant Proc. 1987 Feb; 19(1 Pt 3):2457-8.
        View in: PubMed
      297. So SK, Platt JL, Ascher NL, Snover DC. Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation. 1987 Jan; 43(1):79-85.
        View in: PubMed
      298. Snover DC, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol. 1987 Jan; 11(1):1-10.
        View in: PubMed
      299. Migliori RJ, Simmons RL, Payne WD, Ascher NL, Sutherland DE, Najarian JS, Fryd D. Renal transplantation done safely without prior chronic dialysis therapy. Transplantation. 1987 Jan; 43(1):51-5.
        View in: PubMed
      300. Day DL, Letourneau JG, Allan BT, Ascher NL, Lund G. MR evaluation of the portal vein in pediatric liver transplant candidates. AJR Am J Roentgenol. 1986 Nov; 147(5):1027-30.
        View in: PubMed
      301. Najarian JS, So SK, Simmons RL, Fryd DS, Nevins TE, Ascher NL, Sutherland DE, Payne WD, Chavers BM, Mauer SM. The outcome of 304 primary renal transplants in children (1968-1985). Ann Surg. 1986 Sep; 204(3):246-58.
        View in: PubMed
      302. Ascher NL, Cahill DR, Hoffman RA, Simmons RL. Lymphocytes capable of mediating delayed-type hypersensitivity reactions accumulate within sponge matrix allografts. Surgery. 1986 Aug; 100(2):321-8.
        View in: PubMed
      303. So SK, Mauer SM, Nevins TE, Fryd DS, Sutherland DE, Ascher NL, Simmons RL, Najarian JS. Current results in pediatric renal transplantation at the University of Minnesota. Kidney Int Suppl. 1986 Jul; 19:S25-30.
        View in: PubMed
      304. Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, Claus PL. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology. 1986 Jun; 90(6):2004-7.
        View in: PubMed
      305. Simmons RL, Canafax DM, Fryd DS, Ascher NL, Payne WD, Sutherland DE, Najarian JS. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant Proc. 1986 Apr; 18(2 Suppl 1):76-81.
        View in: PubMed
      306. Canafax DM, Simmons RL, Sutherland DE, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine. Transplant Proc. 1986 Apr; 18(2 Suppl 1):192-6.
        View in: PubMed
      307. McEnery PT, Fine R, Ascher N, Ettenger R, Conley S, Friedman J, Tejani A. Renal transplant immunity and immunosuppression. Am J Kidney Dis. 1986 Apr; 7(4):312-7.
        View in: PubMed
      308. Loken MK, Ascher NL, Boudreau RJ, Najarian JS. Scintigraphic evaluation of liver transplant function. J Nucl Med. 1986 Apr; 27(4):451-9.
        View in: PubMed
      309. Hoffman RA, Hyland BJ, Ascher NL, Simmons RL. The migration of activated T lymphocytes in vitro. III. Paralysis and recovery of locomotor function during mitosis. Transplantation. 1986 Feb; 41(2):214-20.
        View in: PubMed
      310. Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, Payne WD, Sutherland DE, Simmons RL, Najarian JS. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation. 1986 Feb; 41(2):177-81.
        View in: PubMed
      311. Fath JJ, St Cyr JA, Konstantinides FN, Alden P, Ascher NL, Bianco RW, Foker JE, Cerra FB. Alterations in amino acid clearance during ischemia predict hepatocellular ATP changes. Surgery. 1985 Sep; 98(3):396-404.
        View in: PubMed
      312. Simmons RL, Canafax DM, Strand M, Ascher NL, Payne WD, Sutherland DE, Najarian JS. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Transplant Proc. 1985 Aug; 17(4 Suppl 1):266-75.
        View in: PubMed
      313. Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kidney Dis. 1985 Jun; 5(6):318-27.
        View in: PubMed
      314. Najarian JS, Fryd DS, Strand M, Canafax DM, Ascher NL, Payne WD, Simmons RL, Sutherland DE. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg. 1985 Feb; 201(2):142-57.
        View in: PubMed
      315. Tuchman M, Freese DK, Sharp HL, Whitley CB, Ramnaraine ML, Ulstrom RA, Najarian JS, Ascher N, Buist NR, Terry AB. Persistent succinylacetone excretion after liver transplantation in a patient with hereditary tyrosinaemia type I. J Inherit Metab Dis. 1985; 8(1):21-4.
        View in: PubMed
      316. Sutherland DE, Weiland D, Chavers B, Simmons RL, Ascher NL, Najarian JS. Information and long-term follow-up of a large number of related kidney donors at a single institution. Neth J Med. 1985; 28(6):254-6.
        View in: PubMed
      317. Najarian JS, Weiland D, Chavers B, Simmons RL, Payne WD, Ascher NL, Sutherland DE. Studies on living related kidney donors at a single institution. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985; 21:911-9.
        View in: PubMed
      318. Bentley FR, Sutherland DE, Fryd DS, Kaufman D, Ascher NL, Simmons RL, Najarian JS. Similar renal allograft functional survival rates for kidneys from sibling donors matched for zero-versus-one haplotype with the recipient. Transplantation. 1984 Dec; 38(6):674-9.
        View in: PubMed
      319. Sutherland DE, Fryd DS, So SK, Bentley FR, Ascher NL, Simmons RL, Najarian JS. Long-term effect of splenectomy versus no splenectomy in renal transplant patients. Reanalysis of a randomized prospective study. Transplantation. 1984 Dec; 38(6):619-24.
        View in: PubMed
      320. Orosz CG, Ferguson RM, Olson S, Ascher N. A functional assay for cyclosporine in patient serum. Transplant Proc. 1984 Dec; 16(6):1624-5.
        View in: PubMed
      321. Olson SA, Ascher NL, Orosz CG, Najarian JS. Comparison of modes of action of different immunosuppressive agents. Transplant Proc. 1984 Dec; 16(6):1637-8.
        View in: PubMed
      322. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology. 1984 Nov-Dec; 4(6):1212-22.
        View in: PubMed
      323. Najarian JS, Ascher NL. Liver transplantation. N Engl J Med. 1984 Nov 1; 311(18):1179-81.
        View in: PubMed
      324. Hellerstedt WL, Johnson WJ, Ascher N, Kjellstrand CM, Knutson R, Shapiro FL, Sterioff S. Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc. 1984 Nov; 59(11):776-83.
        View in: PubMed
      325. Fath JJ, Ascher NL, Konstantinides FN, Bloomer J, Sharp H, Najarian JS, Cerra FB. Metabolism during hepatic transplantation: indicators of allograft function. Surgery. 1984 Oct; 96(4):664-74.
        View in: PubMed
      326. Sutherland DE, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression. Transplant Proc. 1984 Jun; 16(3):629-32.
        View in: PubMed
      327. Sutherland DE, Strand M, Fryd DS, Ferguson RM, Simmons RL, Ascher NL, Najarian JS. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation. Am J Kidney Dis. 1984 May; 3(6):456-61.
        View in: PubMed
      328. Ascher NL, Najarian JS. Hepatic transplantation and biliary atresia: early experience in eight patients. World J Surg. 1984 Feb; 8(1):57-63.
        View in: PubMed
      329. Ascher NL, Hoffman RA, Hanto DW, Simmons RL. Cellular basis of allograft rejection. Immunol Rev. 1984; 77:217-32.
        View in: PubMed
      330. Canafax DM, Ascher NL. Cyclosporine immunosuppression. Clin Pharm. 1983 Nov-Dec; 2(6):515-24.
        View in: PubMed
      331. Ascher NL, Chen S, Hoffman RA, Simmons RL. Maturation of cytotoxic T cells within sponge matrix allografts. J Immunol. 1983 Aug; 131(2):617-21.
        View in: PubMed
      332. Sharp HL, Ascher NL. The community physician and liver transplantation. Pediatrics. 1983 Aug; 72(2):260-1.
        View in: PubMed
      333. Hoffman RA, Ascher NL, Hanto DW, Simmons RL. The migration of activated murine T lymphocytes in vitro. II. Evidence for differential locomotion of T cell subsets. J Immunol. 1983 Apr; 130(4):1610-5.
        View in: PubMed
      334. Ascher NL, Hoffman R, Hanto DW, Simmons RL. Cellular events within the rejecting allograft. Transplantation. 1983 Mar; 35(3):193-7.
        View in: PubMed
      335. Hoffman RA, Ascher NL, Nelson RD, Simmons RL. Migration of mouse lymphocytes in vitro. I. Normal lymph node lymphocytes. Transplantation. 1981 Mar; 31(3):195-200.
        View in: PubMed
      336. Ascher NL, Chen S, Hoffman R, Simmons RL. Maturation of cytotoxic effector cells at the site of allograft rejection. Transplant Proc. 1981 Mar; 13(1 Pt 2):1105-7.
        View in: PubMed
      337. Hoffman RA, Ascher NL, Simmons RL. Migratory behavior of lymphocytes during allograft rejection. Transplant Proc. 1981 Mar; 13(1 Pt 2):1102-4.
        View in: PubMed
      338. Ascher NL, Hoffman R, Chen S, Simmons RL. Evidence for local helper and suppressor function at the site of allograft rejection. Surgery. 1980 Aug; 88(2):274-80.
        View in: PubMed
      339. Ascher NL, Forstrom L, Simmons RL. Radiolabeled autologous leukocyte scanning in abscess detection. World J Surg. 1980 Jul; 4(4):395-402.
        View in: PubMed
      340. Ascher NL, Hoffman R, Chen S, Simmons RL. Specific and nonspecific infiltration of sponge matrix allografts by specifically sensitized cytotoxic lymphocytes. Cell Immunol. 1980 Jun; 52(1):38-47.
        View in: PubMed
      341. Ascher NL, Simmons RL, Fryd D, Noreen H, Najarian JS. Effects of HLA-A and B matching on success of cadaver grafts at a single center. Transplantation. 1979 Sep; 28(3):172-8.
        View in: PubMed
      342. Ascher NL, Ferguson RM, Hoffman R, Simmons RL. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation. 1979 Apr; 27(4):254-9.
        View in: PubMed
      343. Ascher NL, Ahrenholz DH, Simmons RL, Weiblen B, Gomez L, Forstrom LA, Frick MP, Henke C, McCullough J. Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis. Arch Surg. 1979 Apr; 114(4):386-92.
        View in: PubMed
      344. Marker SC, Ascher NL, Kalis JM, Simmons RL, Najarian JS, Balfour HH. Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. Surgery. 1979 Apr; 85(4):433-40.
        View in: PubMed
      345. Ascher NL, Hoffman R, Simmons RL. Relative absence of helper cells in rejecting allografts. Transplant Proc. 1979 Mar; 11(1):796-9.
        View in: PubMed
      346. Najarian JS, Ascher NL. Causes and management of rejection. Transplant Proc. 1979 Mar; 11(1):11-6.
        View in: PubMed
      347. Ascher NL, Simmons RL, Noreen H, VanHook J, Howard RJ, Sutherland DE, Najarian JS. 100 HLA-identical sibling transplants. Prognostic factors other than histocompatibility. Ann Surg. 1979 Feb; 189(2):209-16.
        View in: PubMed
      348. Ascher NL, Ahrenholz DH, Simmons RL, Najarian JS. 100 second renal allografts from a single transplantation institution. Transplantation. 1979 Jan; 27(1):30-4.
        View in: PubMed
      349. Ascher NL, Hoffman RA, Simmons RL. Local graft irradiation: effect on cytotoxic cell infiltration. Surg Forum. 1979; 30:272-4.
        View in: PubMed
      350. Chen S, Ascher NL, Bach FH, Simmons RL. Graft rejection in donor-recipient pairs with differing of H-2 loci. Surg Forum. 1979; 30:274-6.
        View in: PubMed
      351. Mozes MF, Ascher NL, Balfour HH, Simmons RL, Najarian JS. Jaundice after renal allotransplantation. Ann Surg. 1978 Dec; 188(6):783-90.
        View in: PubMed
      352. Ascher NL, Simmons RL, Marker S, Klugman J, Najarian JS. Tuberculous joint disease in transplant patients. Am J Surg. 1978 Jun; 135(6):853-6.
        View in: PubMed
      353. Ascher NL, Simmons RL, Marker S, Najarian JS. Listeria infection in transplant patients. Five cases and a review of the literature. Arch Surg. 1978 Jan; 113(1):90-4.
        View in: PubMed
      354. Ascher NL, Simmons RL, Fryd DS, Najarian JS. Superior results of well matched cadaveric grafts as compared to parental grafts. Proc Clin Dial Transplant Forum. 1977; 7:11-7.
        View in: PubMed
      355. Dent TL, Weber TR, Lindenauer SM, Ascher N, Weatherbee L, Allen E, Spencer HH. Cryopreservation of vein grafts. Surg Forum. 1974; 25(0):241-3.
        View in: PubMed
      Nancy's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP